The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N03 | Antiepileptics | |
3 | N03A | Antiepileptics | |
4 | N03AG | Fatty acid derivatives |
Code | Title | |
---|---|---|
N03AG01 | Valproic acid | |
N03AG02 | Valpromide | |
N03AG03 | Aminobutyric acid | |
N03AG04 | Vigabatrin | |
N03AG05 | Progabide | |
N03AG06 | Tiagabine |
Active Ingredient | Description | |
---|---|---|
Tiagabine |
Tiagabine is an anti-epileptic drug. Tiagabine is a potent and selective inhibitor of both neuronal and glial GABA uptake, which results in an increase in GABAergic medicated inhibition in the brain. |
|
Valproic acid |
Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. |
|
Valpromide |
|
|
Vigabatrin |
Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain. |
Title | Information Source | Document Type | |
---|---|---|---|
CONVULEX Gastro-resistant capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DEPAKENE Oral solution | Health Products and Food Branch (CA) | MPI, CA: SPM | |
DEPAKINE CHRONO Prolonged-release tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
EPILIM CHRONOSPHERE Modified release granules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
EPILIM Powder and solvent for solution for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
EPIVAL Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
GABITRIL Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
KIGABEQ Soluble tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
RUBILIM Prolonged release tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
SABRIL Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
VIGAFYDE Oral solution | MPI, US: SPL/PLR |